Beamion LUNG-1: A study to test different doses of zongertinib in people with different types of advanced cancer (solid tumours with changes in the HER2 gene)

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-511246-39-00

Acronym

1479-0001

Enrollment

162

Registered

2024-09-25

Start date

2021-07-27

Completion date

Unknown

Last updated

2025-10-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-small cell lung cancer, Solid tumours with HER2 aberrations

None listed

Sex/Gender

All

Age

18 Years to No maximum

Belgium, France, Germany, Italy, Netherlands, Portugal, Spain, Sweden

None listed

Source: EU CTIS · Data processed: Feb 4, 2026